Skip to content
10-Q

Quarterly Report

HEMAGEN DIAGNOSTICS INC

0001445866-12-000603

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2012 · Jun 30, 2012 15.5M sh
Shares Diluted Q3 2012 · Jun 30, 2012 15.49M sh
Operating Cash Flow Q3 2012 · Jun 30, 2012 −$307.85K
Cash And Equivalents Q3 2012 · Jun 30, 2012 $107.31K
Cash And Equivalents Q3 2012 · Sep 30, 2011 $213.61K
Stockholders Equity Q3 2012 · Jun 30, 2012 −$3.43M
Stockholders Equity Q3 2012 · Sep 30, 2011 −$2.69M
Current Liabilities Q3 2012 · Jun 30, 2012 $1.91M
Current Liabilities Q3 2012 · Sep 30, 2011 $1.53M
Total Liabilities Q3 2012 · Jun 30, 2012 $5.96M
Total Liabilities Q3 2012 · Sep 30, 2011 $5.58M
Current Assets Q3 2012 · Jun 30, 2012 $2.14M
Current Assets Q3 2012 · Sep 30, 2011 $2.45M
Total Assets Q3 2012 · Jun 30, 2012 $2.52M
Total Assets Q3 2012 · Sep 30, 2011 $2.89M
Eps Diluted Q3 2012 · Jun 30, 2012 −$0.01
Eps Diluted Q3 2012 · Jun 30, 2012 −$0.05
Eps Basic Q3 2012 · Jun 30, 2012 −$0.01
Eps Basic Q3 2012 · Jun 30, 2012 −$0.05
Sga Expense Q3 2012 · Jun 30, 2012 $465.28K
Sga Expense Q3 2012 · Jun 30, 2012 $1.58M
Rd Expense Q3 2012 · Jun 30, 2012 $483
Rd Expense Q3 2012 · Jun 30, 2012 $26.53K
Net Income Q3 2012 · Jun 30, 2012 −$132.13K
Net Income Q3 2012 · Jun 30, 2012 −$744.33K
Net Income Q3 2012 · Jun 30, 2011 −$48.08K
Net Income Q3 2012 · Jun 30, 2011 −$598.6K
Operating Income Q3 2012 · Jun 30, 2012 −$12.3K
Operating Income Q3 2012 · Jun 30, 2012 −$394.21K
Gross Profit Q3 2012 · Jun 30, 2012 $453.46K
Gross Profit Q3 2012 · Jun 30, 2012 $1.21M
Cost Of Revenue Q3 2012 · Jun 30, 2012 $494.35K
Cost Of Revenue Q3 2012 · Jun 30, 2012 $1.95M
Revenue Q3 2012 · Jun 30, 2012 $947.81K
Revenue Q3 2012 · Jun 30, 2012 $3.17M
Shares Outstanding Q3 2012 · May 14, 2012 15.5M sh